4.6 Article

Inhibition of high-mobility group box 1 improvesmyocardial fibrosis and dysfunction in diabetic cardiomyopathy

期刊

INTERNATIONAL JOURNAL OF CARDIOLOGY
卷 172, 期 1, 页码 202-212

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2014.01.011

关键词

Diabetic cardiomyopathy; High-mobility group box 1; Fibrosis; Cardiac fibroblasts

资金

  1. National Natural Science Foundation of China [81170275, 81370412]
  2. National 973 Basic Research Program of China [2011CB503906, 2012CB518603]
  3. Program of Introducing Talents of Discipline to Universities [B07035]
  4. State Program of National Natural Science Foundation of China for Innovative Research Group [81021001]
  5. State Key Program of National Natural Science of China [61331001]
  6. International Collaboration and Exchange Program of China [81320108004]

向作者/读者索取更多资源

Background: High-mobility group box 1 (HMGB1) is an important mediator of the inflammatory response. Its expression is increased in diabetic cardiomyopathy (DCM), but its role is unclear. We investigated the potential role and mechanism of HMGB1 in diabetes-induced myocardial fibrosis and dysfunction in mice. Methods: In vivo, type 1 diabetes was induced by streptozotocin (STZ) in mice. HMGB1 expression was knocked down by lentivirus-mediated short-hairpin RNA (shRNA). Cardiac function was assessed by echocardiography. Total collagen deposition was assessed by Masson's trichrome and Picrosirius red staining. HMGB1, collagen I and III, and transforming growth factor beta 1 (TGF-beta 1) expression was quantified by immunostaining and western bolt analysis. In vitro, isolated neonatal cardiac fibroblasts were treated with high glucose (HG) or recombinant HMGB1 (rHMGB1). Pharmacologic (neutralizing anti-HMGB1 antibody) or genetic (shRNA-HMGB1) inhibition of HMGB1 was used to investigate the role of HMGB1 in HG-induced functional changes of cardiac fibroblasts. Results: In vivo, HMGB1 was diffusely expressed in the myocardium of diabetic mice. HMGB1 silencing ameliorated left ventricular dysfunction and remodeling and decreased collagen deposition in diabetic mice. In vitro, HG induced HMGB1 translocation and secretion in both viable cardiomyocytes and fibroblasts. Administration of rHMGB1 dose-dependently increased the expression of collagens I and III and TGF-beta 1 in cardiac fibroblasts. HMGB1 inhibition reduced HG-induced collagen production, matrix metalloproteinase (MMP) activities, proliferation, and activated mitogen-activated protein kinase signaling in cardiac fibroblasts. Conclusions: HMGB1 inhibition could alleviate cardiac fibrosis and remodeling in diabetic cardiomyopathy. Inhibition of HMGB1 might have therapeutic potential in the treatment of the disease. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据